Arterial-phase contrast-enhanced ultrasonography for evaluating anti-angiogenesis treatment: A pilot study

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 8

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

276

HTML

3000

Figures (1-5)

209

Tables (1-2)

224

Sum=3709

Feb 28, 2011 (publication date) through Nov 19, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Feb 28, 2011; 17(8): 1045-1050
Published online Feb 28, 2011. doi: 10.3748/wjg.v17.i8.1045

Full Size Figure Download Figure

Figure 3 Contrast-enhanced ultrasonography examination showed that time to peak intensity was delayed in the sorafenib-treated group.

Citation: Yoshida K, Hirokawa T, Moriyasu F, Liu L, Liu GJ, Yamada M, Imai Y. Arterial-phase contrast-enhanced ultrasonography for evaluating anti-angiogenesis treatment: A pilot study. World J Gastroenterol 2011; 17(8): 1045-1050
URL: https://www.wjgnet.com/1007-9327/full/v17/i8/1045.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i8.1045